Dual host and pathogen targeting by MEK1/2 inhibitors

Area of Science:

• Immunology and Pharmacology
• Infectious Diseases
• Molecular Biology

Background:

• Therapeutic strategies often focus on host response modulation to reduce infection-induced inflammation and tissue damage.
• Limited therapeutic options exist that possess both host-modulatory and direct antimicrobial properties.
• Mitogen-activated protein kinase kinase (MEK)1/2 inhibitors are small molecules with recognized antiviral and antibacterial activities.

Purpose of the Study:

• To review the effects of MEK1/2 inhibitors on host innate immune cells.
• To summarize experimental models evaluating MEK1/2 inhibitors in infection and injury.
• To discuss the direct and indirect antimicrobial effects and distinct roles of MEK1 and MEK2.

Main Methods:

• Literature review of studies investigating MEK1/2 inhibitors in infectious and injury models.
• Analysis of research on MEK1/2 inhibitor interactions with host innate immune cells.
• Examination of data on antiviral, antibacterial, and antiparasitic effects of MEK1/2 inhibitors.

Main Results:

• MEK1/2 inhibitors demonstrate antiviral effects by inhibiting viral replication in epithelial cells.
• These compounds exhibit direct antibacterial effects against Gram-positive bacteria.
• MEK1/2 inhibitors have shown anti-inflammatory effects in vivo across various infection models.

Conclusions:

• MEK1/2 inhibitors represent a promising class of therapeutics with dual anti-infective and anti-inflammatory actions.
• Further research into the specific roles of MEK1 and MEK2 could refine therapeutic strategies.
• These inhibitors hold potential for treating a range of infectious diseases by modulating host response and directly targeting pathogens.